BELLUS Health Inc.
BLU was delisted on the 28th of June, 2023.
49 hedge funds and large institutions have $137M invested in BELLUS Health Inc. in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 8
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
2% more funds holding
Funds holding: 48 → 49 (+1)
25% less capital invested
Capital invested by funds: $182M → $137M (-$44.9M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$6.29M |
| 2 |
Millennium Management
New York
|
+$2.8M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.33M |
| 4 |
ACM
Altium Capital Management
New York
|
+$823K |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$802K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$9.73M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.43M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$477K |
| 4 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$175K |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$84K |
BLU Hedge Fund Activity: Q2 2021 in Review
49 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q2 2021, worth a combined $137M — down 25% from $182M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new BLU positions and 5 closed out — a net gain of 1 holder — while 16 added to existing stakes and 8 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $6.29M. The largest seller was Avidity Partners Management, cutting an estimated $9.73M.
- 49 institutional investors held BELLUS Health Inc. (BLU) as of Q2 2021, up from 48 in Q1 2021.
- Funds reported $137M of BELLUS Health Inc. stock for Q2 2021, down 25% quarter-over-quarter.
- 6 funds opened new BELLUS Health Inc. positions in Q2 2021 and 5 closed out, a net change of +1 holder.
- The largest BELLUS Health Inc. buyer in Q2 2021 was Citadel Advisors, an estimated $6.29M added.
- The largest BELLUS Health Inc. seller in Q2 2021 was Avidity Partners Management, an estimated $9.73M sold.
Based on aggregated 13F filings for Q2 2021.